Biotech company shares plummet after ending potentially groundbreaking Alzheimer's drug trial

  • 📰 The Independent
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 59%

Colombia Noticias Noticias

Colombia Últimas Noticias,Colombia Titulares

The company said the decision to end the trial was not based on safety concerns

Biogen, one of the largest biotechs in the world, said the decision to stop the study was not based on safety concerns.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

 /  🏆 80. in CO
 

Gracias por tu comentario. Tu comentario será publicado después de ser revisado.

Colombia Últimas Noticias, Colombia Titulares